Nautilus Biotechnology Inc (NAUT) — Financial Flexibility Index
Nautilus Biotechnology Inc (NAUT) has a Financial Flexibility Index of -0.33x as of September 2025. Free cash flow of $-10.62 Million (operating CF $-11.03 Million minus capex $418.00K) represents 0% of total liabilities ($31.78 Million). Also explore NAUT net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nautilus Biotechnology Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Nautilus Biotechnology Inc across 7 annual periods. Check Nautilus Biotechnology Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Nautilus Biotechnology Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Nautilus Biotechnology Inc. For the full company profile including market capitalisation, see how much is Nautilus Biotechnology Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.68x | $-57.02 Million | $-59.15 Million | $34.01 Million | ▼ -36.8% |
| 2023 | -1.23x | $-49.27 Million | $-51.71 Million | $40.21 Million | ▲ +1.0% |
| 2022 | -1.24x | $-43.48 Million | $-45.81 Million | $35.13 Million | ▼ -16.8% |
| 2021 | -1.06x | $-36.97 Million | $-39.24 Million | $34.87 Million | ▼ -830.3% |
| 2020 | -0.11x | $-13.07 Million | $-14.00 Million | $114.73 Million | ▲ +99.4% |
| 2019 | -17.83x | $-8.74 Million | $-9.66 Million | $490.00K | ▼ -953.6% |
| 2018 | -1.69x | $-238.30 Million | $-238.30 Million | $140.82 Million | — |